Global Luseogliflozin Market Growth 2023-2029

March 2023 | 74 pages | ID: G084A3561181EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Luseogliflozin (trade name Lusefi) is a pharmaceutical drug used for the treatment of type 2 diabetes mellitus.

LPI (LP Information)' newest research report, the “Luseogliflozin Industry Forecast” looks at past sales and reviews total world Luseogliflozin sales in 2022, providing a comprehensive analysis by region and market sector of projected Luseogliflozin sales for 2023 through 2029. With Luseogliflozin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Luseogliflozin industry.

This Insight Report provides a comprehensive analysis of the global Luseogliflozin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Luseogliflozin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Luseogliflozin market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Luseogliflozin and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Luseogliflozin.

The global Luseogliflozin market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

Cardioprotective Effect of Luseogliflozin in Patients with Type 2 Diabetes and Established Cardiovascular Disease.

This report presents a comprehensive overview, market shares, and growth opportunities of Luseogliflozin market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

• 2.5mg
• 5mg

Segmentation by application

• Diabetes
• Heart Disease
• Periodontitis

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Taisho Toyama
• Novartis
• Mitsubishi Tanabe Pharma
• CR Double-Crane

Key Questions Addressed in this Report

What is the 10-year outlook for the global Luseogliflozin market?

What factors are driving Luseogliflozin market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Luseogliflozin market opportunities vary by end market size?

How does Luseogliflozin break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Luseogliflozin Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Luseogliflozin by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Luseogliflozin by Country/Region, 2018, 2022 & 2029
2.2 Luseogliflozin Segment by Type
  2.2.1 2.5mg
  2.2.2 5mg
2.3 Luseogliflozin Sales by Type
  2.3.1 Global Luseogliflozin Sales Market Share by Type (2018-2023)
  2.3.2 Global Luseogliflozin Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Luseogliflozin Sale Price by Type (2018-2023)
2.4 Luseogliflozin Segment by Application
  2.4.1 Diabetes
  2.4.2 Heart Disease
  2.4.3 Periodontitis
2.5 Luseogliflozin Sales by Application
  2.5.1 Global Luseogliflozin Sale Market Share by Application (2018-2023)
  2.5.2 Global Luseogliflozin Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Luseogliflozin Sale Price by Application (2018-2023)

3 GLOBAL LUSEOGLIFLOZIN BY COMPANY

3.1 Global Luseogliflozin Breakdown Data by Company
  3.1.1 Global Luseogliflozin Annual Sales by Company (2018-2023)
  3.1.2 Global Luseogliflozin Sales Market Share by Company (2018-2023)
3.2 Global Luseogliflozin Annual Revenue by Company (2018-2023)
  3.2.1 Global Luseogliflozin Revenue by Company (2018-2023)
  3.2.2 Global Luseogliflozin Revenue Market Share by Company (2018-2023)
3.3 Global Luseogliflozin Sale Price by Company
3.4 Key Manufacturers Luseogliflozin Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Luseogliflozin Product Location Distribution
  3.4.2 Players Luseogliflozin Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR LUSEOGLIFLOZIN BY GEOGRAPHIC REGION

4.1 World Historic Luseogliflozin Market Size by Geographic Region (2018-2023)
  4.1.1 Global Luseogliflozin Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Luseogliflozin Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Luseogliflozin Market Size by Country/Region (2018-2023)
  4.2.1 Global Luseogliflozin Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Luseogliflozin Annual Revenue by Country/Region (2018-2023)
4.3 Americas Luseogliflozin Sales Growth
4.4 APAC Luseogliflozin Sales Growth
4.5 Europe Luseogliflozin Sales Growth
4.6 Middle East & Africa Luseogliflozin Sales Growth

5 AMERICAS

5.1 Americas Luseogliflozin Sales by Country
  5.1.1 Americas Luseogliflozin Sales by Country (2018-2023)
  5.1.2 Americas Luseogliflozin Revenue by Country (2018-2023)
5.2 Americas Luseogliflozin Sales by Type
5.3 Americas Luseogliflozin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Luseogliflozin Sales by Region
  6.1.1 APAC Luseogliflozin Sales by Region (2018-2023)
  6.1.2 APAC Luseogliflozin Revenue by Region (2018-2023)
6.2 APAC Luseogliflozin Sales by Type
6.3 APAC Luseogliflozin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Luseogliflozin by Country
  7.1.1 Europe Luseogliflozin Sales by Country (2018-2023)
  7.1.2 Europe Luseogliflozin Revenue by Country (2018-2023)
7.2 Europe Luseogliflozin Sales by Type
7.3 Europe Luseogliflozin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Luseogliflozin by Country
  8.1.1 Middle East & Africa Luseogliflozin Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Luseogliflozin Revenue by Country (2018-2023)
8.2 Middle East & Africa Luseogliflozin Sales by Type
8.3 Middle East & Africa Luseogliflozin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Luseogliflozin
10.3 Manufacturing Process Analysis of Luseogliflozin
10.4 Industry Chain Structure of Luseogliflozin

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Luseogliflozin Distributors
11.3 Luseogliflozin Customer

12 WORLD FORECAST REVIEW FOR LUSEOGLIFLOZIN BY GEOGRAPHIC REGION

12.1 Global Luseogliflozin Market Size Forecast by Region
  12.1.1 Global Luseogliflozin Forecast by Region (2024-2029)
  12.1.2 Global Luseogliflozin Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Luseogliflozin Forecast by Type
12.7 Global Luseogliflozin Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Taisho Toyama
  13.1.1 Taisho Toyama Company Information
  13.1.2 Taisho Toyama Luseogliflozin Product Portfolios and Specifications
  13.1.3 Taisho Toyama Luseogliflozin Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Taisho Toyama Main Business Overview
  13.1.5 Taisho Toyama Latest Developments
13.2 Novartis
  13.2.1 Novartis Company Information
  13.2.2 Novartis Luseogliflozin Product Portfolios and Specifications
  13.2.3 Novartis Luseogliflozin Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Novartis Main Business Overview
  13.2.5 Novartis Latest Developments
13.3 Mitsubishi Tanabe Pharma
  13.3.1 Mitsubishi Tanabe Pharma Company Information
  13.3.2 Mitsubishi Tanabe Pharma Luseogliflozin Product Portfolios and Specifications
  13.3.3 Mitsubishi Tanabe Pharma Luseogliflozin Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Mitsubishi Tanabe Pharma Main Business Overview
  13.3.5 Mitsubishi Tanabe Pharma Latest Developments
13.4 CR Double-Crane
  13.4.1 CR Double-Crane Company Information
  13.4.2 CR Double-Crane Luseogliflozin Product Portfolios and Specifications
  13.4.3 CR Double-Crane Luseogliflozin Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 CR Double-Crane Main Business Overview
  13.4.5 CR Double-Crane Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Luseogliflozin Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Luseogliflozin Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 2.5mg
Table 4. Major Players of 5mg
Table 5. Global Luseogliflozin Sales by Type (2018-2023) & (K Units)
Table 6. Global Luseogliflozin Sales Market Share by Type (2018-2023)
Table 7. Global Luseogliflozin Revenue by Type (2018-2023) & ($ million)
Table 8. Global Luseogliflozin Revenue Market Share by Type (2018-2023)
Table 9. Global Luseogliflozin Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Luseogliflozin Sales by Application (2018-2023) & (K Units)
Table 11. Global Luseogliflozin Sales Market Share by Application (2018-2023)
Table 12. Global Luseogliflozin Revenue by Application (2018-2023)
Table 13. Global Luseogliflozin Revenue Market Share by Application (2018-2023)
Table 14. Global Luseogliflozin Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Luseogliflozin Sales by Company (2018-2023) & (K Units)
Table 16. Global Luseogliflozin Sales Market Share by Company (2018-2023)
Table 17. Global Luseogliflozin Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Luseogliflozin Revenue Market Share by Company (2018-2023)
Table 19. Global Luseogliflozin Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Luseogliflozin Producing Area Distribution and Sales Area
Table 21. Players Luseogliflozin Products Offered
Table 22. Luseogliflozin Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Luseogliflozin Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Luseogliflozin Sales Market Share Geographic Region (2018-2023)
Table 27. Global Luseogliflozin Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Luseogliflozin Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Luseogliflozin Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Luseogliflozin Sales Market Share by Country/Region (2018-2023)
Table 31. Global Luseogliflozin Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Luseogliflozin Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Luseogliflozin Sales by Country (2018-2023) & (K Units)
Table 34. Americas Luseogliflozin Sales Market Share by Country (2018-2023)
Table 35. Americas Luseogliflozin Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Luseogliflozin Revenue Market Share by Country (2018-2023)
Table 37. Americas Luseogliflozin Sales by Type (2018-2023) & (K Units)
Table 38. Americas Luseogliflozin Sales by Application (2018-2023) & (K Units)
Table 39. APAC Luseogliflozin Sales by Region (2018-2023) & (K Units)
Table 40. APAC Luseogliflozin Sales Market Share by Region (2018-2023)
Table 41. APAC Luseogliflozin Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Luseogliflozin Revenue Market Share by Region (2018-2023)
Table 43. APAC Luseogliflozin Sales by Type (2018-2023) & (K Units)
Table 44. APAC Luseogliflozin Sales by Application (2018-2023) & (K Units)
Table 45. Europe Luseogliflozin Sales by Country (2018-2023) & (K Units)
Table 46. Europe Luseogliflozin Sales Market Share by Country (2018-2023)
Table 47. Europe Luseogliflozin Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Luseogliflozin Revenue Market Share by Country (2018-2023)
Table 49. Europe Luseogliflozin Sales by Type (2018-2023) & (K Units)
Table 50. Europe Luseogliflozin Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Luseogliflozin Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Luseogliflozin Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Luseogliflozin Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Luseogliflozin Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Luseogliflozin Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Luseogliflozin Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Luseogliflozin
Table 58. Key Market Challenges & Risks of Luseogliflozin
Table 59. Key Industry Trends of Luseogliflozin
Table 60. Luseogliflozin Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Luseogliflozin Distributors List
Table 63. Luseogliflozin Customer List
Table 64. Global Luseogliflozin Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Luseogliflozin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Luseogliflozin Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Luseogliflozin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Luseogliflozin Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Luseogliflozin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Luseogliflozin Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Luseogliflozin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Luseogliflozin Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Luseogliflozin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Luseogliflozin Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Luseogliflozin Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Luseogliflozin Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Luseogliflozin Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Taisho Toyama Basic Information, Luseogliflozin Manufacturing Base, Sales Area and Its Competitors
Table 79. Taisho Toyama Luseogliflozin Product Portfolios and Specifications
Table 80. Taisho Toyama Luseogliflozin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Taisho Toyama Main Business
Table 82. Taisho Toyama Latest Developments
Table 83. Novartis Basic Information, Luseogliflozin Manufacturing Base, Sales Area and Its Competitors
Table 84. Novartis Luseogliflozin Product Portfolios and Specifications
Table 85. Novartis Luseogliflozin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Novartis Main Business
Table 87. Novartis Latest Developments
Table 88. Mitsubishi Tanabe Pharma Basic Information, Luseogliflozin Manufacturing Base, Sales Area and Its Competitors
Table 89. Mitsubishi Tanabe Pharma Luseogliflozin Product Portfolios and Specifications
Table 90. Mitsubishi Tanabe Pharma Luseogliflozin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Mitsubishi Tanabe Pharma Main Business
Table 92. Mitsubishi Tanabe Pharma Latest Developments
Table 93. CR Double-Crane Basic Information, Luseogliflozin Manufacturing Base, Sales Area and Its Competitors
Table 94. CR Double-Crane Luseogliflozin Product Portfolios and Specifications
Table 95. CR Double-Crane Luseogliflozin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. CR Double-Crane Main Business
Table 97. CR Double-Crane Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Luseogliflozin
Figure 2. Luseogliflozin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Luseogliflozin Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Luseogliflozin Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Luseogliflozin Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 2.5mg
Figure 10. Product Picture of 5mg
Figure 11. Global Luseogliflozin Sales Market Share by Type in 2022
Figure 12. Global Luseogliflozin Revenue Market Share by Type (2018-2023)
Figure 13. Luseogliflozin Consumed in Diabetes
Figure 14. Global Luseogliflozin Market: Diabetes (2018-2023) & (K Units)
Figure 15. Luseogliflozin Consumed in Heart Disease
Figure 16. Global Luseogliflozin Market: Heart Disease (2018-2023) & (K Units)
Figure 17. Luseogliflozin Consumed in Periodontitis
Figure 18. Global Luseogliflozin Market: Periodontitis (2018-2023) & (K Units)
Figure 19. Global Luseogliflozin Sales Market Share by Application (2022)
Figure 20. Global Luseogliflozin Revenue Market Share by Application in 2022
Figure 21. Luseogliflozin Sales Market by Company in 2022 (K Units)
Figure 22. Global Luseogliflozin Sales Market Share by Company in 2022
Figure 23. Luseogliflozin Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Luseogliflozin Revenue Market Share by Company in 2022
Figure 25. Global Luseogliflozin Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Luseogliflozin Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Luseogliflozin Sales 2018-2023 (K Units)
Figure 28. Americas Luseogliflozin Revenue 2018-2023 ($ Millions)
Figure 29. APAC Luseogliflozin Sales 2018-2023 (K Units)
Figure 30. APAC Luseogliflozin Revenue 2018-2023 ($ Millions)
Figure 31. Europe Luseogliflozin Sales 2018-2023 (K Units)
Figure 32. Europe Luseogliflozin Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Luseogliflozin Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Luseogliflozin Revenue 2018-2023 ($ Millions)
Figure 35. Americas Luseogliflozin Sales Market Share by Country in 2022
Figure 36. Americas Luseogliflozin Revenue Market Share by Country in 2022
Figure 37. Americas Luseogliflozin Sales Market Share by Type (2018-2023)
Figure 38. Americas Luseogliflozin Sales Market Share by Application (2018-2023)
Figure 39. United States Luseogliflozin Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Luseogliflozin Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Luseogliflozin Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Luseogliflozin Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Luseogliflozin Sales Market Share by Region in 2022
Figure 44. APAC Luseogliflozin Revenue Market Share by Regions in 2022
Figure 45. APAC Luseogliflozin Sales Market Share by Type (2018-2023)
Figure 46. APAC Luseogliflozin Sales Market Share by Application (2018-2023)
Figure 47. China Luseogliflozin Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Luseogliflozin Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Luseogliflozin Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Luseogliflozin Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Luseogliflozin Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Luseogliflozin Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Luseogliflozin Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Luseogliflozin Sales Market Share by Country in 2022
Figure 55. Europe Luseogliflozin Revenue Market Share by Country in 2022
Figure 56. Europe Luseogliflozin Sales Market Share by Type (2018-2023)
Figure 57. Europe Luseogliflozin Sales Market Share by Application (2018-2023)
Figure 58. Germany Luseogliflozin Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Luseogliflozin Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Luseogliflozin Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Luseogliflozin Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Luseogliflozin Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Luseogliflozin Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Luseogliflozin Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Luseogliflozin Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Luseogliflozin Sales Market Share by Application (2018-2023)
Figure 67. Egypt Luseogliflozin Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Luseogliflozin Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Luseogliflozin Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Luseogliflozin Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Luseogliflozin Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Luseogliflozin in 2022
Figure 73. Manufacturing Process Analysis of Luseogliflozin
Figure 74. Industry Chain Structure of Luseogliflozin
Figure 75. Channels of Distribution
Figure 76. Global Luseogliflozin Sales Market Forecast by Region (2024-2029)
Figure 77. Global Luseogliflozin Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Luseogliflozin Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Luseogliflozin Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Luseogliflozin Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Luseogliflozin Revenue Market Share Forecast by Application (2024-2029)